Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution?

Mazzaferri, 1999, Oncology, 13, 391

Schlumberger, 1997, Thyroid, 7, 273, 10.1089/thy.1997.7.273

Pacini, 1987, J Nucl Med, 28, 1888

Pineda, 1995, J Clin Endocrinol Metab, 80, 1488

Schlumberger, 1998, N Engl J Med, 338, 297, 10.1056/NEJM199801293380506

Sherman, 1994, J Clin Endocrinol Metab, 78, 629

Grigsby, 1998, Cancer, 82, 931, 10.1002/(SICI)1097-0142(19980301)82:5<931::AID-CNCR19>3.0.CO;2-1

Fatourechi, 2000, Thyroid, 10, 573, 10.1089/thy.2000.10.573

Schlumberger, 1996, J Nucl Med, 37, 598

Tubiana, 1985, Cancer, 55, 2062, 10.1002/1097-0142(19850501)55:9+<2062::AID-CNCR2820551406>3.0.CO;2-O

Reynolds, 1997, Thyroid, 7, 281, 10.1089/thy.1997.7.281

Brierley, 1998, 285

Mazzaferri, 2001, J Clin Endocrinol Metab, 86, 1447, 10.1210/jcem.86.4.7407

Miccoli, 1998, Arch Surg, 133, 89, 10.1001/archsurg.133.1.89

Tenenbaum, 1996, Eur J Cancer, 32A, 1262, 10.1016/0959-8049(96)00020-2